Certara Synchrogenix Information
Summary
Certara Synchrogenix is a public company that has been in the industry for 17 years. The company currently specializes in the Pharmaceuticals, Biotechnology, Pharmaceuticals areas. The position of the CEO is occupied by William F. Feehery. Its headquarters is located at Princeton, New Jersey, USA. The number of employees ranges from 500 to 1.0K. The annual revenue of Certara Synchrogenix varies between 100M and 500M. Total funding of the company - $1.5B. To connect with Certara Synchrogenix employee register on SignalHire.
Industries
Pharmaceuticals
Headquarters Location
Employees Size
200-500 employees
Specialties
Regulatory writing, Strategic document development, Clinical trial disclosure, Support of Modules 1-5 of CTD, Medical writing, Scientific writing, Submission leadership - NDA, MAA, BLA, IND, ANDA, 505b2, Redaction, artificial intelligence, Regulatory Operations, Publishing, Regulatory consulting, PMTA, MRTPA, eCTD
SIC Code
8000
DMA Code
New York Metropolitan Area
Founded
1986
Estimated Annual Revenue
$100M - 500M
Operating Status
Acquired
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2012 | Privately Held | 100 - 250 | 5.1M | $849M | |
| 1990 | Public Company | 250 - 500 | 120.7M | $394.6M | |
| 1996 | Public Company | 100 - 250 | 46.2M | $5.8M | |
| 2007 | Privately Held | 25 - 100 | 8.3M | $19.7M | |
| 2014 | Privately Held | 1 - 25 | 1.3M | $1M | |
| 2012 | Privately Held | 100 - 250 | 8M | $176.3M | |
| 2010 | Privately Held | 25 - 100 | 9M | $30.8M | |
| 2005 | Privately Held | 25 - 100 | 9M | $0 |
Employees Turnover 2 quarter 2025
Length of Employment
